Ledger.Open graph →
SEC Form D · filed March 3, 2026

Allyx Therapeutics, Inc

Offering
$4.0M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW HAVEN, CT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Jennifer A. Gabler · New Haven, CTExecRobert A. Bettigole · New Haven, CTDirectorPaul Fonteyne · Sarasota, FLDirectorGregory P. Ho · New York, NYDirectorStephen Strittmatter · New Haven, CTDirectorStephen Bloch · MORRISVILLE, NCExec · DirectorTimothy A. Siegert · New Haven, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗